October 2018

New protections for biologics and other pharmaceuticals under the United States-Mexico-Canada Agreement (USMCA)

By Kristin Wall & Christopher A. Guerreiro on October 14, 2018

As we reported, Canada has joined a new trilateral trade deal called the United States-Mexico-Canada Agreement (USMCA). The USMCA contains important new protections for biologic and other pharmaceutical innovation. Chief among them, Canada will introduce an extended…

Abbreviated New Drug Submissions will be posted on the Submissions Under Review List and other pre-market transparency initiatives

By Kristin Wall on October 14, 2018

Health Canada recently published a notice outlining its phase III pre-market transparency initiatives for prescription drugs. Beginning October 1, 2018, Health Canada will publish a new list of abbreviated new drug submissions (ANDSs) on the Submissions Under Review…

Pharma in Brief

October 2018

New protections for biologics and other pharmaceuticals under the United States-Mexico-Canada Agreement (USMCA)

Abbreviated New Drug Submissions will be posted on the Submissions Under Review List and other pre-market transparency initiatives

About

Topics

Archives